Angiotensin III stimulates aldosterone secretion from adrenal gland partially via angiotensin ii type 2 receptor but not angiotensin ii type 1 receptor

Endocrinology

Volumn 152, Issue 4, 2011, Pages 1582-1588

  Yatabe, Junichi ^a,b   Yoneda, Minoru ^b   Yatabe, Midori S ^a   Watanabe, Tsuyoshi ^a   Felder, Robin A ^c   Jose, Pedro A ^d   Sanada, Hironobu ^b  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b NATIONAL VETERINARY ASSAY LABORATORY   (Japan)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; CANDESARTAN; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE;

ADRENAL GLAND; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; DRUG ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ALDOSTERONE; ANGIOTENSIN III; ANIMALS; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ZONA GLOMERULOSA;

EID: 79953220111     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-1070     Document Type: Article

References (37)

1. Bomback AS, Klemmer PJ 2007 The incidence and implications of aldosterone breakthrough. Nat Clin Pract Nephrol 3:486-492 (Pubitemid 47313030)
2. Weber KT, Brilla CG 1991 Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83:1849-1865
3. Robert V, Silvestre JS, Charlemagne D, Sabri A, Trouvé P, Wassef M, Swynghedauw B, Delcayre C 1995 Biological determinants of aldosterone-induced cardiac fibrosis in rats. Hypertension 26:971-978
4. Young M, Fullerton M, Dilley R, Funder J 1994 Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest 93:2578-2583 (Pubitemid 24177174)
5. Schrier RW 2010 Aldosterone 'escape' vs 'breakthrough.' Nat Rev Nephrol 6:61
6. Balla T, Baukal AJ, Eng S, Catt KJ 1991 Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla. Mol Pharmacol 40:401-406
7. Chiu AT, Peach MJ 1974 Inhibition of induced aldosterone biosynthesis with a specific antagonist of angiotensin II. Proc Natl Acad Sci USA 71:341-344
8. Goodfriend TL, Peach MJ 1975 Angiotensin III: (DES-aspartic acid-1)-angiotensin II. Evidence and speculation for its role as an important agonist in the renin-angiotensin system. Circ Res 36:38-48
9. Jöhren O, Golsch C, Dendorfer A, Qadri F, Häuser W, Dominiak P 2003 Differential expression of AT1 receptors in the pituitary and adrenal gland of SHR and WKY. Hypertension 41:984-990 (Pubitemid 36418476)
10. Tanabe A, Naruse M, Naruse K, Yoshimoto T, Tanaka M, Mishina N, Imaki T, Sugaya K, Miyazaki H, Demura H 1999 [Angiotensin II receptor subtype in human adrenal glands]. Nippon Rinsho 57:1042-1048 (Japanese)
11. Mazzocchi G, Gottardo G, Macchi V, Malendowicz LK, Nussdorfer GG 1998 The AT2 receptor-mediated stimulation of adrenal catecholamine release may potentiate the AT1 receptor-mediated aldosterone secretagogue action of angiotensin-II in rats. Endocr Res 24:17-28 (Pubitemid 28166458)
12. Mizuno K, Hoffman LH, McKenzie JC, Inagami T 1988 Presence of renin secretory granules in rat adrenal gland and stimulation of renin secretion by angiotensin II but not by adrenocorticotropin. J Clin Invest 82:1007-1016
13. Epstein M 2006 Aldosterone blockade: an emerging strategy for abrogating progressive renal disease. Am J Med 119:912-919 (Pubitemid 44634312)
14. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M 2003 Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309-1321 (Pubitemid 36384098)
15. Brown NJ 2003 Eplerenone: cardiovascular protection. Circulation 107:2512-2518 (Pubitemid 36605237)
16. Nishiyama A, Abe Y 2006 Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade. J Pharmacol Sci 100:9-16 (Pubitemid 43161608)
17. Foster RH, MacFarlane CH, Bustamante MO 1997 Recent progress in understanding aldosterone secretion. Gen Pharmacol 28:647-651 (Pubitemid 27244412)
18. Espiner E, Nichols M 2002 The Renin Angiotensin System. London: Gower Medical Publishing; 33.1-33.24
19. Naruse M, Tanabe A, Sato A, Takagi S, Tsuchiya K, Imaki T, Takano K 2002 Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats. Hypertension 40:28-33 (Pubitemid 34755975)
20. Remme WJ 1995 Neurohormonal modulation in heart failure: ACE inhibition and beyond. Eur Heart J 16(Suppl N):73-78 (Pubitemid 26082324)
21. Suzuki T, Yamazaki T, Yazaki Y 2001 The role of the natriuretic peptides in the cardiovascular system. Cardiovasc Res 51:489-494 (Pubitemid 32718597)
22. Zia AA, Kamalov G, Newman KP, McGee JE, Bhattacharya SK, Ahokas RA, Sun Y, Gerling IC, Weber KT 2010 From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation. Hypertens Res 33:1091-1101
23. Alsafwah S, Laguardia SP, Arroyo M, Dockery BK, Bhattacharya SK, Ahokas RA, Newman KP 2007 Congestive heart failure is a systemic illness: a role for minerals and micronutrients. Clin Med Res 5:238-243 (Pubitemid 351731693)
24. Rossi GP 2006 Aldosterone breakthrough during RAS blockade: a role for endothelins and their antagonists? Curr Hypertens Rep 8:262-268
25. Athyros VG, Mikhailidis DP, Kakafika AI, Tziomalos K, Karagiannis A 2007 Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution? Expert Opin Pharmacother 8:529-535
26. Saavedra JM, Timmermans PB 1994 Angiotensin receptors. New York: Plenum
27. Tanabe A, Naruse M, Arai K, Naruse K, Yoshimoto T, Seki T, Imaki T, Miyazaki H, Zeng ZP, Demura R, Demura H 1998 Gene expression and roles of angiotensin II type 1 and type 2 receptors in human adrenals. Horm Metab Res 30:490-495 (Pubitemid 28420067)
28. Gammelgaard I, Wamberg S, Bie P 2006 Systemic effects of angiotensin III in conscious dogs during acute double blockade of the renin-angiotensin- aldosterone-system. Acta Physiol (Oxf) 188:129-138 (Pubitemid 44337810)
29. Plovsing RR, Wamberg C, Sandgaard NC, Simonsen JA, Holstein-Rathlou NH, Hoilund-Carlsen PF, Bie P 2003 Effects of truncated angiotensins in humans after double blockade of the renin system. Am J Physiol Regul Integr Comp Physiol 285:R981-R991 (Pubitemid 37296348)
30. Carey RM 2005 Update on the role of the AT2 receptor. Curr Opin Nephrol Hypertens 14:67-71
31. Padia SH, Howell NL, Siragy HM, Carey RM 2006 Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat. Hypertension 47:537-544 (Pubitemid 43843872)
32. Haithcock D, Jiao H, Cui XL, Hopfer U, Douglas JG 1999 Renal proximal tubular AT2 receptor: signaling and transport. J Am Soc Nephrol 10(Suppl 11):S69-S74 (Pubitemid 29038167)
33. Reilly CF, Tewksbury DA, Schechter NM, Travis J 1982 Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J Biol Chem 257:8619-8622 (Pubitemid 12004182)
34. Okunishi H, Miyazaki M, Okamura T, Toda N 1987 Different distribution of two types of angiotensin II-generating enzymes in the aortic wall. Biochem Biophys Res Commun 149:1186-1192 (Pubitemid 18024671)
35. Belova LA 2000 Angiotensin II-generating enzymes. Biochemistry (Mosc) 65:1337-1345 (Pubitemid 33658042)
36. Sun Y, Weber KT 1998 Cardiac remodelling by fibrous tissue: role of local factors and circulating hormones. Ann Med 30(Suppl 1):3-8 (Pubitemid 28414368)
37. Legedz L, Randon J, Sessa C, Baguet JP, Feugier P, Cerutti C, McGregor J, Bricca G 2004 Cathepsin G is associated with atheroma formation in human carotid artery. J Hypertens 22:157-166 (Pubitemid 38293543)